India Glycols Limited has informed the Exchange about Investor Presentation
INDIAGLYCO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
India Glycols Limited delivered strong financial performance in FY26 with Net Revenue of ₹4,211 Cr (up 11.8% YoY), EBITDA of ₹654 Cr (up 24.5% YoY), and PAT of ₹293 Cr (up 26.8% YoY). Q4FY26 also showed robust growth with PAT up 35.7% YoY to ₹87 Cr. Key segment highlights include Potable Spirits revenue of ₹1,331 Cr with 21.4% EBIT margin, Bio-Fuel revenue of ₹1,470 Cr with 40.9% YoY growth and 7.8% margin, and BSPC EBIT margin expansion to 11.7%. Finance costs reduced significantly to ₹26 Cr in Q4FY26 from ₹45 Cr in Q4FY25. Cash generation from operations surged 112.4% YoY to ₹769 Cr in FY26.
Strong margin improvement across BSPC and Bio-Fuel segments, combined with reduced debt costs, indicates operational efficiency gains. The upcoming demerger into three separate listed entities (IGL, IGL Spirits, Ennature Bio Pharma) could unlock shareholder value though restructuring execution risk exists.